King Wealth Management Group’s Genmab GMAB Stock Holding History

King Wealth Management Group’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-16,897	Closed	-$549K	–	159
2022 Q2	$549K	Hold	16,897	–	–	0.13%	78
2022 Q1	$611K	Hold	16,897	–	–	0.12%	83
2021 Q4	$668K	Hold	16,897	–	–	0.12%	84
2021 Q3	$738K	Hold	16,897	–	–	0.15%	79
2021 Q2	$690K	Sell	16,897 -10,000	-37%	-$386K	0.14%	81
2021 Q1	$883K	Buy	26,897 +13,000	+94%	+$489K	0.2%	72
2020 Q4	$565K	Hold	13,897	–	–	0.13%	85
2020 Q3	$509K	Hold	13,897	–	–	0.13%	88
2020 Q2	$471K	Hold	13,897	–	–	0.14%	83
2020 Q1	$294K	Sell	13,897 -8,000	-37%	-$178K	0.13%	97
2019 Q4	$489K	Sell	21,897 -5,000	-19%	-$109K	0.13%	73
2019 Q3	$545K	Buy	+26,897	New	+$530K	0.16%	65

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

King Wealth Management Group's GMAB Position: Q3 2022 in Review

King Wealth Management Group sold out of Genmab (GMAB) in Q3 2022, closing a stake of 16,897 shares — an estimated $549K sold.

King Wealth Management Group first reported a position in GMAB in Q3 2019 and held it in 12 quarters. The position peaked at $883K in Q1 2021. 194 funds tracked by Wall St. Rank hold GMAB as of Q3 2022.

King Wealth Management Group reported no remaining Genmab position as of Q3 2022 after selling out during the quarter.
King Wealth Management Group sold 16,897 Genmab shares in Q3 2022, an estimated $549K.
King Wealth Management Group first reported a position in Genmab in Q3 2019 and held it in 12 quarters.
King Wealth Management Group's Genmab position peaked at $883K in Q1 2021.
194 funds tracked by Wall St. Rank held Genmab as of Q3 2022.

Based on King Wealth Management Group's 13F filing for Q3 2022, filed 10 Nov 2022.